Advertisement
YOU ARE HERE: LAT HomeCollections

The Nation

April 07, 1986

A drug that shortens the course of herpes infections and apparently lengthens the time between eruptions of herpes-related sores may be a breakthrough in treatment of the incurable disorder, a doctor reported. Details of two studies, appearing in the British journal Lancet, show that when intervir-A--not yet approved by the Food and Drug Administration--was applied to herpes sores, the eruptions quickly disappeared, and incidents of recurrent outbreaks were greatly reduced.

Advertisement
Los Angeles Times Articles
|
|
|